Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
The current Merck(MRK) stock price is $116.91, with a market capitalization of 289.58B. The stock trades at a price-to-earnings (P/E) ratio of 15.90 and offers a dividend yield of 2.8%.
On 2026-03-10, Merck(MRK) stock moved within a range of $116.91 to $116.91. With shares now at $116.91, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading volume for Merck(MRK) stock has reached 6.51K, versus its average volume of 11.08M.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.
MRK News
In late February 2026, Merck reported multiple pivotal Phase 3 successes across oncology and HIV, including KEYTRUDA- and WELIREG-based regimens in renal cell,...
In the latest close session, Merck (MRK) was up +1.14% at $117.11. The stock's performance was ahead of the S&P 500's daily gain of 0.83%. At the same time, the...
Merck (NYSE:MRK) has expanded a multi year collaboration with Tempus AI to develop precision medicine biomarkers using advanced AI and machine learning. The co...
Analyst ratings
61%
of 31 ratingsMore MRK News
Key Points ImmunityBio's recently approved cancer drug has plenty of momentum. However, valuation concerns and clinical and regulatory uncertainty make the st...
Advertisement Why Merck (MRK) is Back on Investors’ Radar Merck (MRK) has caught investors’ attention after recent performance data showed a mix of short term...
Tempus AI Inc. (NASDAQ:TEM) on Tuesday inked a strategic collaboration agreement with Merck & Co. Inc. (NYSE:MRK) aimed at accelerating AI-driven precision medi...
Most Retirees Overlook These Dow Dividend Stocks — They Pay More Than You’d Expect Quick Read Chevron (CVX) up 83% over 25 years, Home Depot (HD) up 42% in 5 y...
Merck (NYSE:MRK) reported positive Phase 3 results for KEYTRUDA combinations in renal cell carcinoma, ovarian cancer, and bladder cancer. The company also secu...
Tempus AI (TEM) and Merck (MRK) announced an expanded, multi-year collaboration aimed at accelerating the discovery and development of precision medicine biomar...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.